THE USE OF QALY AS AN INTEGRAL MEASURE OF EFFECTIVENESS IN THE EVALUATION OF MEDICAL TECHNOLOGIES by N. Z. Musina, V. K. Fedyaeva

Get full text

PROSPECTS FOR THE USE OF METHODS OF ECONOMIC EVALUATION AT THE STAGE OF PLANNING AND ORGANISATION OF CLINICAL TRIALS by N. Z. Musina, V. V. Tarasov

Get full text

Evaluation of the reference value of the incremental parameter "cost-effectiveness" for Russian healthcare system by T. S. Teptsova, N. Z. Musina, V. V. Omelyanovsky

Get full text

EARLY HEALTH TECHNOLOGIES ASSESSMENT — NEW APPROACH TO IMPROVING THE EFFICIENCY OF THE MEDICAL TECHNOLOGY DEVELOPMENT PROCESS by N. Z. Musina, V. V. Omelyanovskiy, A. V. Krasheninnikova

Get full text

Introduction of medical products into healthcare practice and costs reimbursement: European experience by V. V. Omelyanovsky, S. S. Otstavnov, N. Z. Musina, V. S. Dombrovskii

Get full text

The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia by V. V. Omelyanovsky, V. K. Fedyaeva, N. Z. Musina

Get full text

Evaluation of the antitumor drugs therapeutic value using the method of multicriterial analysis of decision-making by V. A. Lemeshko, N. Z. Musina, V. V. Omelyanovskiy

Get full text

IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET by V. A. Lemeshko, N. Z. Musina, V. K. Fedyaeva

Get full text

Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions by G. R. Hachatryan, T. S. Teptsova, V. A. Lemeshko, N. Z. Musina

Get full text

Evolution of healthcare provider payment mechanisms by V. V. Omelyanovskiy, N. N. Sisigina, V. K. Fedyaeva, N. Z. Musina

Get full text

Cost-effectiveness analysis of using atorvastatin, simvastatin, ezetimibe, alirocumab, evolocumab, inclisiran in adults with very high cardiovascular risk under the preferential dr... by T. O. Bessonova, P. A. Mukhortova, R. A. Teryan, A. D. Bagdasarov, N. Z. Musina

Get full text

Determination of a willingness-to-pay threshold and decision-making in financing the healthcare technologies by T. S. Teptsova, T. P. Bezdenezhnyh, V. K. Fedyaeva, N. Z Musina, G. R. Hachatryan, V. V. Tarasov

Get full text

International experience in determining the cost-effectiveness thresholds by T. P. Bezdenezhnykh, N. Z. Musina, V. K. Fedyaeva, T. S. Tepcova, V. A. Lemeshko, V. V. Omelyanovsky

Get full text

Pharmacoeconomic analysis of the application of follitropin alfa in combination with assisted reproductive technologies by K. A. Perova, D. G. Shchurov, D. V. Blinov, N. V. Bashmakova, N. Z. Musina

Get full text

THE USE OF MULTI-CRITERIAL DECISION ANALYSIS (MCDA) FOR ESTIMATING THE THERAPEUTIC VALUE OF INNOVATIVE DRUGS by V. K. Fedyaeva, V. V. Omelyanovskiy, N. Z. Musina, G. R. Khachatryan, O. I. Ivakhnenko

Get full text

Affordability of in vivo gene therapy. Problems and potential solutions by V. V. Omelyanovskiy, N. Z. Musina, V. A. Lemeshko, A. A. Antonov, F. V. Gorkavenko

Get full text

Concept of value-based healthcare by N. Z. Musina, V. V. Omelyanovskiy, R. V. Gostischev, O. A. Sukhorukikh, V. K. Fedyaeva, N. N. Sisigina, D. G. Shchurov

Get full text

Review of the current approaches to the assessment of the drug innovative potential worldwide by N. Z. Musina, V. K. Fedyaeva, V. V. Omel’yanovskii, G. R. Khachatryan, K. V. Gerasimova, V. A. Lemeshko, K. P. Konchits

Get full text